Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents
ChemMedChem · 2025
DOI: 10.1002/cmdc.202400902 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Rani Bandela und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Address 1Balanagar, Hyderabad, 500037, Telangan…. Hauptthemen laut MEDLINE: Drug Design, Mycobacterium tuberculosis, Antitubercular Agents, Isoxazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
The continued prevalence of drug‐resistant Mycobacterium tuberculosis (Mtb) strains, particularly against first‐line antitubercular (anti‐TB) drugs, presents an impending public health threat that necessitates the exploration and development of New Chemical Entities (NCEs). In search of new anti‐TB leads, a library of ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) isoxazole‐3‐carboxylates were generated through a strategy of scaffold hopping from the proven isoxazole‐3‐carboxylate‐based anti‐TB pharmacophore. We evaluated their antibacterial potential against a panel of pathogenic bacteria and Mtb H 37 Rv strains. The majority of the compounds exhibited notable in vitro efficacy against the H 37 Rv strains (MIC 0.25 to 16 μ g/mL) and were not cytotoxic with a Selectivity Index (SI) >10. Compound 5e (3,4‐dichlorobenzyl substituent) was found to be optimally active in the lot (MIC 0.25 μ g/mL) and SI >200. It also displayed equipotent activity against drug‐resistant Mtb (DR‐ Mtb ) strains. In addition, it demonstrated concentration‐dependent bactericidal activity in a time‐kill kinetic assay similar to first‐line anti‐TB drugs besides exhibiting synergistic activity with Streptomycin. Moreover, it complies with the drug‐likeness characteristic, making it a promising candidate for further exploration as a probable anti‐TB lead.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Address 1Balanagar, Hyderabad, 500037, Telangana, India.
- School of Pharmacy, GITAM (Deemed to be university), Visakhapatnam, 530045, Andhra Pradesh, India.
- Division of Microbiology and Immunology, CSIR-Central Drug Research Institute, Sitapur Road, Sector 10, Janakipuram Extension, Lucknow, 226031, Uttar Pradesh, India.
- AcSIR: Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
ORCID-Profile: Srinivas Nanduri, Venkata Madhavi Yaddanapudi
Zitieren
APA
Bandela, R., Sahoo, S. K., Mukhopadhyay, A., Imran, M., Singampalli, A., Maddipatla, S., Bellapukonda, S. M., Panchal, D., Nanduri, S., Dasgupta, A., Chopra, S., & Yaddanapudi, V. M. (2025). Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents. ChemMedChem. https://doi.org/10.1002/cmdc.202400902
Vancouver
Bandela R, Sahoo SK, Mukhopadhyay A, Imran M, Singampalli A, Maddipatla S, et al. Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents. ChemMedChem. 2025. doi:10.1002/cmdc.202400902
BibTeX
@article{Bandela2025,
author = {Bandela, Rani and Sahoo, Santosh Kumar and Mukhopadhyay, Atri and Imran, Mohmmad and Singampalli, Anuradha and Maddipatla, Sarvan and Bellapukonda, Sri Mounika and Panchal, Devdhar and Nanduri, Srinivas and Dasgupta, Arunava and Chopra, Sidharth and Yaddanapudi, Venkata Madhavi},
title = {Design, Synthesis and Biological Evaluation of Ethyl 5‐(1‐benzyl‐1 H ‐indol‐5‐yl) Isoxazole‐3‐Carboxylates as Antimycobacterial Agents},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202400902}
}
EUVIMED